• No Development Reported (364)
• Discovery (287)
• Phase 2 Clinical (132)
• Discontinued (63)
• Phase 1 Clinical (63)
• Launched (43)
• Phase 3 Clinical (24)
• Clinical (11)
• Registered (7)
• Pre-registration (4)
• Suspended (3)
• Withdrawn (1)

Refine Clear

• Medipost Co Ltd (10)
• Stemedica Cell Technologies Inc (10)
• FCB-Pharmicell Co Ltd (9)
• Fate Therapeutics Inc (9)
• Boston Biomedical Inc (8)
• Novartis AG (8)
• Pro-Cure Therapeutics Ltd (8)
• University of Minnesota (8)
• Cellerix SA (7)
• Celprogen Inc (7)
• Amgen Inc (6)
• Caladrius Biosciences Inc (6)
• CellPraxis Bioengenharia (6)
• Gamida Cell Ltd (6)
• International Stem Cell Corp (6)

Refine Clear

• Cancer (239)
• Neurology/Psychiatric (89)
• Immune (87)
• Cardiovascular (86)
• Endocrine/Metabolic (49)
• Musculoskeletal (36)
• Hematologic (34)
• Ocular (34)
• Dermatologic (32)
• Gastrointestinal (19)
• Inflammatory (19)
• Infection (15)
• Respiratory (14)
• Unknown (14)
• Cancer; Immune (12)

Refine Clear

• Cancer (29)
• Insulin dependent diabetes (12)
• Osteoarthritis (11)
• Hematopoietic stem cell transplantation (8)
• Acute myelogenous leukemia (7)
• Glioblastoma (7)
• Graft versus host disease (7)
• Unidentified indication (7)
• Alzheimers disease (6)
• Myocardial infarction (6)
• Parkinsons disease (6)
• Severe combined immunodeficiency syndrome (6)
• Cardiac failure (5)
• Cardiovascular disease (5)
• Pancreas tumor (5)

Refine Clear